Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen
Xiang
X
West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Wang
Xianhuo
X
Wang
Yongsheng
Y
Yang
Li
L
Hu
Jia
J
Xiao
Wenjing
W
Fu
Afu
A
Cai
Lulu
L
Li
Xia
X
Ye
Xia
X
Liu
Yalin
Y
Wu
Wenshuang
W
Shao
Ximing
X
Mao
Yongqiu
Y
Wei
Yuquan
Y
Chen
Lijuan
L
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002412:Cations; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry*; D005434:Flow Cytometry; D020287:In Situ Nick-End Labeling; D007275:Injections, Intravenous; D008081:Liposomes; D008297:Male; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018625:Microscopy, Atomic Force; D009368:Neoplasm Transplantation; D017239:Paclitaxel / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D010316:Particle Size; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D011485:Protein Binding; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism; D013499:Surface Properties
D000970:Antineoplastic Agents; D002412:Cations; D004337:Drug Carriers; D008081:Liposomes; D017468:Receptors, Fibroblast Growth Factor; D016222:Fibroblast Growth Factor 2; D004317:Doxorubicin; D017239:Paclitaxel